TeleRare Health has launched a new virtual care platform specifically designed for individuals with rare diseases, aiming to facilitate diagnosis, assess disease progression, and provide ongoing care. Based in Minneapolis, the company connects patients with specialised clinicians and offers a suite of services including molecular diagnostics, care coordination, and referrals to other services. Additionally, it provides information on available treatments for rare diseases and connects patients with advocacy organisations.
The company is committed to reducing the time it takes to diagnose these conditions. "Significant breakthroughs have been made in the management of rare diseases," said Dr. Alex Katz, a medical geneticist and the Chief Medical Officer of TeleRare Health. Despite these advances, Dr. Katz noted that effective treatments are only available for a small percentage of these diseases, and many patients struggle with accessing care.
TeleRare Health plans to assist patients in accessing available medications and facilitate their participation in clinical trials where possible. The platform also focuses on symptom management through video consultations, aiming to proactively address potential health issues before they escalate.
Approximately 25 to 30 million Americans suffer from a rare disease. Advocacy groups like the EveryLife Foundation are pushing for policies that support the rare disease community. Meanwhile, major pharmaceutical companies are increasingly including rare disease therapies in their offerings, leveraging advanced technologies such as AI to develop new treatments.
Click here to read the original news story.